290 related articles for article (PubMed ID: 19704059)
1. Thrombotic events in patients with cancer receiving antiangiogenesis agents.
Zangari M; Fink LM; Elice F; Zhan F; Adcock DM; Tricot GJ
J Clin Oncol; 2009 Oct; 27(29):4865-73. PubMed ID: 19704059
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic complications of angiogenesis inhibitors in cancer patients.
Elice F; Jacoub J; Rickles FR; Falanga A; Rodeghiero F
Am J Hematol; 2008 Nov; 83(11):862-70. PubMed ID: 18819092
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis associated with angiogenesis inhibitors.
Elice F; Rodeghiero F; Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2009 Mar; 22(1):115-28. PubMed ID: 19285278
[TBL] [Abstract][Full Text] [Related]
4. [Thromboembolic risk associated with use of angiogenesis inhibitors used for the treatment of cancers].
Drouet L
Pathol Biol (Paris); 2008 Jun; 56(4):195-204. PubMed ID: 18450388
[TBL] [Abstract][Full Text] [Related]
5. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
[TBL] [Abstract][Full Text] [Related]
6. Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact.
Elice F; Rodeghiero F
Thromb Res; 2010 Apr; 125 Suppl 2():S55-7. PubMed ID: 20434006
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide and thrombosis. A meta-analysis.
El Accaoui RN; Shamseddeen WA; Taher AT
Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
9. Targeting angiogenesis with integrative cancer therapies.
Yance DR; Sagar SM
Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
[TBL] [Abstract][Full Text] [Related]
10. Side effects of anti-angiogenic drugs.
Elice F; Rodeghiero F
Thromb Res; 2012 Apr; 129 Suppl 1():S50-3. PubMed ID: 22682133
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
Ademuyiwa FO; Miller KD
Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of anti-angiogenesis therapy: update for the internist.
Gurevich F; Perazella MA
Am J Med; 2009 Apr; 122(4):322-8. PubMed ID: 19332223
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
Oklu R; Walker TG; Wicky S; Hesketh R
J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide: when everything old is new again.
Nirenberg A
Clin J Oncol Nurs; 2001; 5(1):15-8. PubMed ID: 11899395
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.
Singh A; Gajra A
Cardiovasc Hematol Agents Med Chem; 2011 Jan; 9(1):7-13. PubMed ID: 20874693
[TBL] [Abstract][Full Text] [Related]
16. Thalidomid: current role in the treatment of non-plasma cell malignancies.
Kumar S; Witzig TE; Rajkumar SV
J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and cancer: recent advances.
Cáceres W; González S
P R Health Sci J; 2003 Jun; 22(2):149-51. PubMed ID: 12866139
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
[TBL] [Abstract][Full Text] [Related]
20. Platelets and cancer: implications for antiangiogenic therapy.
Trikha M; Nakada MT
Semin Thromb Hemost; 2002 Feb; 28(1):39-44. PubMed ID: 11885024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]